Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Alkaline Citrate Treatment to Lower the Risk of Nephrocalcinosis in Preterm Infants

NCT00249951 is registered in ClinicalTrials.gov with University of Cologne as lead sponsor.

NCT NCT00249951
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00249951 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Alkaline Citrate Treatment to Lower the Risk of Nephrocalcinosis in Preterm Infants
Lead sponsor
University of Cologne
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2005
Completion date
November 30, 2008
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nephrocalcinosis